LPL Financial’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Buy
43,516
+11,989
+38% +$99.7K ﹤0.01% 5276
2025
Q4
$262K Sell
31,527
-886
-3% -$9.54K ﹤0.01% 5251
2025
Q3
$473K Buy
32,413
+951
+3% +$11.4K ﹤0.01% 4676
2025
Q2
$354K Buy
31,462
+9,099
+41% +$70.5K ﹤0.01% 4653
2025
Q1
$127K Buy
22,363
+3,434
+18% +$35K ﹤0.01% 4985
2024
Q4
$186K Sell
18,929
-4,988
-21% -$42.8K ﹤0.01% 4836
2024
Q3
$195K Buy
23,917
+9,124
+62% +$91.4K ﹤0.01% 4733
2024
Q2
$198K Buy
14,793
+590
+4% +$17.6K ﹤0.01% 4573
2024
Q1
$659K Buy
14,203
+2,279
+19% +$118K ﹤0.01% 3548
2023
Q4
$806K Buy
11,924
+1,675
+16% +$103K ﹤0.01% 3250
2023
Q3
$742K Buy
10,249
+3,184
+45% +$255K ﹤0.01% 3167
2023
Q2
$526K Buy
7,065
+1,851
+36% +$110K ﹤0.01% 3403
2023
Q1
$277K Buy
5,214
+619
+13% +$39.2K ﹤0.01% 3802
2022
Q4
$311K Buy
4,595
+211
+5% +$19.4K ﹤0.01% 3623
2022
Q3
$547K Buy
4,384
+1,762
+67% +$210K ﹤0.01% 3071
2022
Q2
$250K Buy
+2,622
New +$320K ﹤0.01% 3774
2022
Q1
Sell
-349
Closed -$116K 4245
2021
Q4
$116K Sell
349
-107
-23% -$50.8K ﹤0.01% 4117
2021
Q3
$212K Buy
+456
New +$222K ﹤0.01% 3937

Other funds holding DNA